FDA found Cronobacter in Perrigo infant formula and facility; company recalled some Gerber Good Start Soothe Pro.
What happened
FDA inspected the Eau Claire, Wisconsin powdered infant formula plant from March 6 through April 26, 2023. FDA found Cronobacter spp. in finished products from three production campaigns and in environmental swabs; some environmental strains matched strains found at the same facility in March 2022. The company recalled impacted Gerber Good Start Soothe Pro batches in March 2023 after FDA review and discussions.
What FDA found
The company did not have process controls for all production stages designed to keep microorganisms out of the infant formula.
21 C.F.R. § 106.55(a)Finished infant formula products tested positive for Cronobacter spp. in three production campaigns.
21 C.F.R. § 106.55(a)Root cause investigations did not use DNA fingerprinting (whole genome sequencing) or swab surfaces before cleaning to compare bacteria found in product and facility.
21 C.F.R. § 106.55(a)FDA environmental swabs found C. sakazakii, and two strains matched strains found at the same facility in March 2022, indicating resident pathogens or places where the bacterium can persist.
21 C.F.R. § 106.55(a)The company did not clearly define corrective actions for pathogen detections and did not investigate positive pathogen samples from high-potential product-contact areas.
21 C.F.R. § 106.55(a)The company did not show its dry cleaning was sufficient to control microbiological contamination and did not consider missing sanitation breaks in product disposition decisions.
21 C.F.R. § 106.55(a)
What FDA wants
FDA tells Perrigo to fix gaps in its root cause investigations, evaluate sanitation and hygienic controls when deciding product disposition, and continue looking for places where the bacterium can persist; FDA will check corrective actions at the next inspection. The letter text provided does not state a response deadline.
Who should pay attention
- infant formula brand owners and distributors
- contract manufacturers of powdered infant formula
- quality teams managing environmental monitoring and product disposition
This is a summary. Read the original letter on fda.gov.